Valuation: Brooks Laboratories Limited

Market Cap 1.89B 20.01M 18.15M 16.77M 15.15M 28.56M 29.56M 202M 79.91M 1.01B 75.09M 73.5M 3.2B P/E 2025
-28.6x
P/E 2026 4.45x
Enterprise Value 1.9B 20.21M 18.33M 16.94M 15.3M 28.84M 29.85M 204M 80.69M 1.02B 75.82M 74.22M 3.23B EV / Sales 2025
3.93x
EV / Sales 2026 1.3x
Free-Float
45.16%
Yield 2025 *
-
Yield 2026 -
11-07 Brooks Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026 CI
10-14 Brooks Laboratories Limited agreed to Spin-Off Abridge Speciality Limited. CI
09-16 Brooks Laboratories Limited Announces Resignation of Krutika Rane as Company Secretary and Compliance Officer (Key Managerial Personnel), Effective October 9, 2026 CI
08-13 Brooks Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
07-17 Brooks Laboratories Limited Announces Appointment of Rajesh Mahajan to President Trading and Senior Management Personnel, Effective July 17, 2026 CI
06-19 Steriscience Specialties Private Limited agreed to acquire an additional 16.33% stake in Brooks Steriscience Limited from Brooks Laboratories Limited for INR 1.1 billion. CI
05-29 Brooks Laboratories appoints Prashant Rathi as CEO RE
05-29 Brooks Laboratories names Prashant Rathi as CEO RE
05-29 Brooks Laboratories Limited Announces Appointment of Prashant Rathi as Chief Executive Officer, Effective June 1, 2026 CI
05-29 Brooks Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-06 Brooks Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
16/10/25 Brooks Laboratories Limited Announces That Mr. Rajesh Mahajan Resigned as President - Procurement, with Effect from 16 October 2025 CI
13/08/25 Brooks Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
1 day-2.99%
1 week-3.66%
Current month+5.71%
1 month-2.32%
3 months+2.46%
6 months+28.53%
Current year-20.11%
1 week 63.31
Extreme 63.31
69.75
1 month 55.5
Extreme 55.5
73.4
Current year 36.3
Extreme 36.3
82.44
1 year 36.3
Extreme 36.3
112.33
3 years 36.3
Extreme 36.3
198.86
5 years 36.3
Extreme 36.3
198.86
10 years 13.85
Extreme 13.85
198.86
Manager TitleAgeSince
Chief Executive Officer 58 23/01/2002
Chief Executive Officer - 01/06/2026
President 58 23/08/2023
Director TitleAgeSince
Director/Board Member 53 23/11/2022
Director/Board Member 62 10/09/2010
Director/Board Member - 23/08/2023
Change 5-day change 1-year change 3-year change Capi.($)
-2.99%-3.66%-37.45%-48.80% 20.68M
+1.26%+5.77%+41.83%+141.51% 1,271B
+0.79%+4.93%+47.00%+94.06% 683B
+0.20%+2.36%+26.50%+112.88% 520B
-0.44%+3.32%+39.36%+70.94% 389B
+0.55%+0.56%+61.57%+45.73% 362B
-0.12%-0.04%+28.04%+59.86% 304B
+0.37%-0.43%+3.43%+38.57% 286B
-0.30%+1.17%+38.48%+74.21% 253B
+0.08%+0.30%+36.21%+121.39% 208B
Average -0.36%+1.49%+28.50%+71.03% 428B
Weighted average by Cap. -0.25%+2.67%+38.22%+98.28%

Financials

2025 2026
Net sales 826M 8.76M 7.95M 7.34M 6.63M 12.5M 12.94M 88.25M 34.98M 441M 32.87M 32.18M 1.4B 857M 9.1M 8.25M 7.63M 6.89M 12.99M 13.44M 91.65M 36.33M 458M 34.14M 33.42M 1.45B
Net income -99.67M -1.06M -959K -887K -801K -1.51M -1.56M -10.65M -4.22M -53.25M -3.97M -3.88M -169M 246M 2.61M 2.37M 2.19M 1.98M 3.72M 3.85M 26.28M 10.42M 131M 9.79M 9.58M 417M
Net Debt 75.39M 800K 726K 671K 606K 1.14M 1.18M 8.06M 3.19M 40.28M 3M 2.94M 128M 18.44M 196K 177K 164K 148K 279K 289K 1.97M 781K 9.85M 734K 719K 31.25M
Projected Income Statement - Annual - Brooks Laboratories Limited
Logo Brooks Laboratories Limited
Brooks Laboratories Limited is an India-based pharmaceutical manufacturing company. The Company specializes in supplying pharmaceutical products to government bodies, healthcare institutions, and large organizations. It operates through two segments, which include manufacturing and trading. The manufacturing segment comprises its own manufacturing operations and loan-licensing business relating to pharmaceutical products, ingredients, and intermediaries. The trading segment comprises principal-to-principal trading activities in pharmaceutical products, ingredients, and intermediaries. Its General Products offerings include Liquid Injection (Ampoules), Liquid Injection (Vials), Dry Powder Injections (Vials), Lyophilised Injections, Eye/Ear Drops, and Nasal Drops. The Company's Critical Care Division (CCD), operates through a robust distribution network, delivering injectables to hospitals and healthcare institutions across India.
Employees
347
Date Price Change Volume
13/11/26 ₹64.02 -2.99% 38,427
12/11/26 ₹65.99 -1.71% 36,521
11/11/26 ₹67.14 +2.11% 55,190
09/11/26 ₹65.75 -0.32% 24,798
08/11/26 ₹65.96 +4.28% 32,326
  1. Stock Market
  2. Stocks
  3. BROOKS Stock